Mark Eisner's Net Worth
$1.33 Million
Who is Mark Eisner?
Mark Eisner has an estimated net worth of $1.33 Million. This is based on reported shares in FIBROGEN INC.
SEC CIK
Mark Eisner's CIK is 0001834161
Past Insider Trading and Trends
2023 was Mark Eisner's most active year for acquiring shares with 4 total transactions. Mark Eisner's most active month to acquire stocks was the month of January. 2023 was Mark Eisner's most active year for disposing of shares, totalling 9 transactions. Mark Eisner's most active month to dispose stocks was the month of February. 2022 saw Mark Eisner paying a total of $0.00 for 160,000 shares, this is the most they've acquired in one year. In 2023 Mark Eisner cashed out on 33,949 shares for a total of $617,261.82, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FIBROGEN INC (FGEN) Snapshot price: $2.1486
EVP, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.15% | -1.86K |
$0.96 | -$1,791.37 | 159.92K |
Sep 6
| |||
Form 4
| -0.67% | -1.08K |
$1.06 | -$1,150.10 | 161.78K |
Sep 1
| |||
Form 4
| -1.24% | -2.04K |
$17.04 | -$34,791.60 | 162.86K |
Jun 7
| |||
Form 4
| -0.66% | -1.09K |
$18.83 | -$20,524.70 | 164.9K |
Jun 2
| |||
Form 4
| -5.24% | -9.18K |
$18.78 | -$172,472.85 | 165.99K |
Apr 4
| |||
Form 4
| +1.55% | 2.68K |
$20.60 | -$360,571.51 | 175.18K |
Mar 8 - Mar 10
| |||
Form 4
| -0.68% | -1.19K |
$21.87 | -$25,959.69 | 172.5K |
Mar 2
| |||
Form 4
| +23.02% | 32.5K |
—
|
—
| 173.68K |
Feb 21
| |||
Form 4
| -0.76% | -1.08K |
$15.04 | -$16,303.36 | 141.18K |
Dec 1
| |||
Form 4
| -4.55% | -6.78K |
$13.01 | -$88,168.77 | 142.27K |
Sep 30
| |||
Form 4
| -0.50% | -756.00 |
$13.09 | -$9,896.04 | 149.04K |
Sep 1
| |||
Form 4
| -0.76% | -1.14K |
$9.61 | -$10,965.01 | 149.8K |
Jun 1
| |||
Form 4
| -4.09% | -6.44K |
$12.02 | -$77,432.84 | 150.94K |
Mar 31
| |||
Form 4
| -0.48% | -756.00 |
$13.62 | -$10,296.72 | 157.38K |
Mar 1
| |||
Form 4
| +61.14% | 60K |
—
|
—
| 158.14K |
Feb 14
| |||
Form 4
| -6.70% | -7.04K |
$14.82 | -$104,377.26 | 98.14K |
Jan 3
| |||
Form 4
| -3.96% | -4.34K |
$12.65 | -$54,875.70 | 105.18K |
Dec 1
| |||
Form 4
| +212.91% | 74.52K |
—
|
—
| 109.52K |
Oct 4
| |||
Form 4
|
∞
| 35K |
—
|
—
| 35K |
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vir Biotechnology, Inc. (VIR) No price found
EVP and Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 75K |
—
|
—
| 75K |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||